Congress Presses FDA To Speak Up On OTC/Supplement Combo Products

Congressional interest turns up the pressure on FDA to make a statement on Bayer Aspirin with Heart Advantage, and issue a definitive policy on any products that combine dietary supplement and OTC drug ingredients